Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator.

about

Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator.

Item

http://www.wikidata.org/entity/Q55412053

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Safety, Efficacy and Evidence ...... le Cardioverter Defibrillator.

@en

Safety, Efficacy and Evidence ...... le Cardioverter Defibrillator.

@nl

type

Item

label

Safety, Efficacy and Evidence ...... le Cardioverter Defibrillator.

@en

Safety, Efficacy and Evidence ...... le Cardioverter Defibrillator.

@nl

prefLabel

Safety, Efficacy and Evidence ...... le Cardioverter Defibrillator.

@en

Safety, Efficacy and Evidence ...... le Cardioverter Defibrillator.

@nl

P1476

Safety, Efficacy and Evidence ...... ble Cardioverter Defibrillator

@en

P2093

Carmen Adduci

http://www.w3.org/2001/XMLSchema#string

Pietro Francia

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis

A systematic review of ICD complications in randomised controlled trials versus registries: is our 'real-world' data an underestimation?

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry

An entirely subcutaneous implantable cardioverter-defibrillator.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.

Clinical experience with a novel subcutaneous implantable defibrillator system in a single center.

P31

scholarly article

P356

10.3390/JCM7030053

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Palano

P577

2018-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29534478

http://www.w3.org/2001/XMLSchema#string

P921

defibrillator

P932

5867579

http://www.w3.org/2001/XMLSchema#string